Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Helen J. MacKay"'
Autor:
Kevin Yijun Fan, Rania Chehade, Andrew Yuanbo Wang, Anjali Sachdeva, Helen J. MacKay, Amandeep S. Taggar
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2610-2619 (2024)
Small-cell neuroendocrine carcinoma of the cervix (SCNECC) is a rare cancer with poor prognosis, with limited data to guide its treatment. The objective of this study was to evaluate practice patterns in the management of SCNECC. A 23-question online
Externí odkaz:
https://doaj.org/article/77c2912ea4d3456482cb10af4b20fb1c
Publikováno v:
Cancer Medicine, Vol 9, Iss 14, Pp 5035-5050 (2020)
Abstract Background Clinical trial reports often emphasize efficacy over harms, leading to misinterpretation of the risk‐to‐benefit ratio of new therapies. Clear and sufficiently detailed reporting of methods and results is especially important i
Externí odkaz:
https://doaj.org/article/57963f3e6aa24a5f8ac96a0f10d1fcbd
Autor:
Sarah Fremond, Sonali Andani, Jurriaan Barkey Wolf, Jouke Dijkstra, Sinéad Melsbach, Jan J Jobsen, Mariel Brinkhuis, Suzan Roothaan, Ina Jurgenliemk-Schulz, Ludy C H W Lutgens, Remi A Nout, Elzbieta M van der Steen-Banasik, Stephanie M de Boer, Melanie E Powell, Naveena Singh, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Vincent T H B M Smit, Carien L Creutzberg, Nanda Horeweg, Viktor H Koelzer, Tjalling Bosse
Publikováno v:
The Lancet Digital Health, 5(2), e71-e82. Lancet Publishing Group
The Lancet Digital Health, 5(2), e71-e82. Elsevier
The Lancet Digital Health, 5(2), e71-e82. Elsevier Ltd.
The Lancet Digital Health, 5(2), e71-e82. Elsevier
The Lancet Digital Health, 5(2), e71-e82. Elsevier Ltd.
Background: Endometrial cancer can be molecularly classified into POLEmut, mismatch repair deficient (MMRd), p53 abnormal (p53abn), and no specific molecular profile (NSMP) subgroups. We aimed to develop an interpretable deep learning pipeline for wh
Autor:
Geoffrey Liu, Eitan Amir, Helen J. Mackay, Sevtap Savas, Anke H. Maitland-van der Zee, Wei Xu, Vincent Pang, Steven Habbous, Abul Kalam Azad, Lawson Eng
PDF file, 113K, Supplementary Tables 4-7: These tables summarize in detail, the prognostic associations of VEGF pathway polymorphisms with drug response/survival on survival parameters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16cab5d3dabaaf00896b3e2d4fb2d660
https://doi.org/10.1158/1078-0432.22454967.v1
https://doi.org/10.1158/1078-0432.22454967.v1
Autor:
Geoffrey Liu, Eitan Amir, Helen J. Mackay, Sevtap Savas, Anke H. Maitland-van der Zee, Wei Xu, Vincent Pang, Steven Habbous, Abul Kalam Azad, Lawson Eng
Angiogenesis is an important host process that interacts with cancer cells to promote growth, invasion, and metastasis. Numerous therapeutic agents targeting the VEGF pathway have been developed. Host variability in VEGF pathway can influence angioge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90253659b3130bc00a02873a85d3b98f
https://doi.org/10.1158/1078-0432.c.6522888
https://doi.org/10.1158/1078-0432.c.6522888
Autor:
Geoffrey Liu, Eitan Amir, Helen J. Mackay, Sevtap Savas, Anke H. Maitland-van der Zee, Wei Xu, Vincent Pang, Steven Habbous, Abul Kalam Azad, Lawson Eng
PDF file, 160K, Supplementary Figure 1: This figure displays the forest plots for both the A) pooled and B) zygosity-segregated analysis of VEGF +936C>T as a prognostic marker of overall survival in cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e32c8ca75770d976f218f41d0db9d4f8
https://doi.org/10.1158/1078-0432.22454979
https://doi.org/10.1158/1078-0432.22454979
Autor:
Geoffrey Liu, Eitan Amir, Helen J. Mackay, Sevtap Savas, Anke H. Maitland-van der Zee, Wei Xu, Vincent Pang, Steven Habbous, Abul Kalam Azad, Lawson Eng
PDF file, 141K, Supplementary Figures 2-4: These figures display the pooled meta-analysis results and forest plots of the other three VEGF polymorphisms analyzed (VEGF -2578C>A, -1154G>A, -460C>T).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fc5dc28c467a589e85ed8cca5caa4cf
https://doi.org/10.1158/1078-0432.22454976.v1
https://doi.org/10.1158/1078-0432.22454976.v1
Autor:
Geoffrey Liu, Eitan Amir, Helen J. Mackay, Sevtap Savas, Anke H. Maitland-van der Zee, Wei Xu, Vincent Pang, Steven Habbous, Abul Kalam Azad, Lawson Eng
PDF file, 59K, Supplementary Table 1: Summary of sequence variants/polymorphisms found in systematic review and their common, Human Genome Variation Society (HGVS) and RefSNP annotations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c46608ccb7136ac4f832c78113219d
https://doi.org/10.1158/1078-0432.22454973.v1
https://doi.org/10.1158/1078-0432.22454973.v1
Publikováno v:
Journal of Cancer Policy. 36:100421
Publikováno v:
Cancer Research. 83:206-206
While most patients with high grade serous ovarian cancer (HGSC) respond to platinum-based chemotherapy, the response is rarely durable and recurrence almost inevitable. Women with triple negative breast cancer (TNBC) urgently require effective thera